FAQ: What Employers and Employees Should Know About GLP-1 Coverage, Costs and Access

A recent Navitus Pulse Survey of 2,000 Americans who use or have used GLP-1 therapies found that cost influenced 68% of decisions to start or continue treatment. Building on the findings, Managed Healthcare Executive explored key questions for employers and employees around coverage, costs and access, highlighting the growing challenge of balancing affordability, safety and demand for GLP-1 therapies.